FeesSafety
Pluang+

Big Ten schools compete to boost blood donations amid national shortage, with $1M prize from Abbott.

Market News
12 Aug 2026
PRNewsWire
View Source
Bullish
Big Ten schools compete to boost blood donations amid national shortage, with $1M prize from Abbott.

Abbott and the Big Ten Conference have launched the "We Give Blood" drive, a nationwide competition among all 18 Big Ten universities to increase blood donations amid a national blood shortage declared by the American Red Cross. The campaign runs from August 12 to December 4, encouraging anyone in the U.S. to donate blood and log their donation for a Big Ten school to help address both immediate shortages and long-term donor sustainability. The winning school will receive $1 million to support student or community health initiatives, with the winner announced at the Big Ten Football Championship Game on December 5, 2026. This effort aims to recruit younger donors as nearly a quarter of current donations come from donors over 65, ensuring a stable blood supply for the future.

More News (ABT)

New Abbott test shows 10.6-fold higher risk of colorectal cancer recurrence post-surgery via sensitive DNA detection.

New Abbott test shows 10.6-fold higher risk of colorectal cancer recurrence post-surgery via sensitive DNA detection.

Abbott announced results from the Beta-CORRECT study showing its Oncodetect test, using whole-genome sequencing, improves detection of molecular residual disease (MRD) in colorectal cancer patients after surgery. The test showed a 30% higher sensitiv...

Market News
Bullish
22 hours ago
Abbott to spin off Nutrition unit, focusing on faster-growing diagnostics and devices

Abbott to spin off Nutrition unit, focusing on faster-growing diagnostics and devices

Abbott Laboratories announced plans to spin off its Nutrition division to concentrate on higher-growth areas like diagnostics, medical devices, and pharmaceuticals. The company reported a 14.5% increase in Q3 revenue to $13.01 billion, driven mainly ...

Company Fundamentals
Bearish
2 days ago
Abbott reports mixed Q3 2026 results, lowers sales growth forecast, plans to spin off nutrition business.

Abbott reports mixed Q3 2026 results, lowers sales growth forecast, plans to spin off nutrition business.

Abbott Laboratories reported Q3 2026 results with adjusted earnings per share of $1.42, matching estimates, and revenue of $13.01 billion, slightly above expectations. Despite 14.5% sales growth, the company lowered its 2026 sales growth forecast due...

Company Fundamentals
Neutral
2 days ago
Abbott reports 14.5% sales growth in Q3 2026, raises full-year EPS guidance amid new product launches

Abbott reports 14.5% sales growth in Q3 2026, raises full-year EPS guidance amid new product launches

Abbott posted a 14.5% increase in reported sales and 7.0% comparable sales growth for Q3 2026, with GAAP diluted EPS of $0.53 and adjusted EPS of $1.42. The company expanded its portfolio with FDA approvals for innovative products like the Libre Duo ...

Company Fundamentals
Bullish
3 days ago
Abbott to spin off Nutrition business into independent company by end of 2027

Abbott to spin off Nutrition business into independent company by end of 2027

Abbott announced plans to separate its Nutrition business into a standalone, publicly traded company by the end of 2027. The new Nutrition company will focus on the growing healthy nutrition market with $8.5 billion in annual sales and iconic brands ...

Company Fundamentals
Bullish
3 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App